Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt

Journal of Animal Science

Volumn 86, Issue 11, 2008, Pages 2897-2902

  McDaneld, T G ^a,b   Spurlock, D M ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b U S MEAT ANIMAL RESEARCH CENTER   (United States)

Author keywords

Ankyrin; Differentiation; Muscle; Myoblast

Indexed keywords

ASB15 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MYOBLAST; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASES; MYOBLASTS; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 55849092908     PISSN: 00218812     EISSN: None     Source Type: Journal    
DOI: 10.2527/jas.2008-1076     Document Type: Article

References (21)

1. Bennett, A. M., and N. K. Tonks. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291.
2. Coolican, S. A., D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini. 1997. The mitogenic and myogenic actions of insulinlike growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653-6662.
3. Florini, J. R. 1989. Assay of creatine kinase in microtiter plates using thio-NAD to allow monitoring at 405 nm. Anal. Biochem. 182:399-404.
4. Guibal, F. C., C. Moog-Lutz, P. Smolewski, Y. Di Gioia, Z. Darzynkiewicz, P. G. Lutz, and Y. E. Cayre. 2002. ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J. Biol. Chem. 277:218-224.
5. Han, B., J. Tong, M. J. Zhu, C. Ma, and M. Du. 2008. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway. Mol. Reprod. Dev. 75:810-817.
6. Hilton, D. J., R. T. Richardson, W. S. Alexander, E. M. Viney, T. A. Willson, N. S. Sprigg, R. Starr, S. E. Nicholson, D. Metcalf, and N. A. Nicola. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95:114-119.
7. Jiang, B. H., J. Z. Zheng, and P. K. Vogt. 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc. Natl. Acad. Sci. USA 95:14179-14183.
8. Jones, N. C., Y. V. Fedorov, R. S. Rosenthal, and B. B. Olwin. 2001. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J. Cell. Physiol. 186:104-115.
9. Kile, B. T., E. M. Viney, T. A. Willson, T. C. Brodnicki, M. R. Cancilla, A. S. Herlihy, B. A. Croker, M. Baca, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 2000. Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins ASB-1, ASB-2, ASB-3 and ASB-4. Gene 258:31-41.
10. Kohroki, J., S. Fujita, N. Itoh, Y. Yamada, H. Imai, N. Yumoto, T. Nakanishi, and K. Tanaka. 2001. ATRA-regulated ASB-2 gene induced in differentiation of HL-60 leukemia cells. FEBS Lett. 505:223-228.
11. Latres, E., A. R. Amini, A. A. Amini, J. Griffiths, F. J. Martin, Y. Wei, H. C. Lin, G. D. Yancopoulos, and D. J. Glass. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J. Biol. Chem. 280:2737-2744.
12. McDaneld, T. G., D. L. Hancock, and D. E. Moody. 2004. Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists. Physiol. Genomics 16:275-283.
13. McDaneld, T. G., K. Hannon, and D. E. Moody. 2006. Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R1672-R1682.
14. Moelling, K., K. Schad, M. Bosse, S. Zimmermann, and M. Schweneker. 2002. Regulation of Raf-Akt cross-talk. J. Biol. Chem. 277:31099-31106.
15. Pena, T. L., S. H. Chen, S. F. Konieczny, and S. G. Rane. 2000. Ras/ MEK/ERK Up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J. Biol. Chem. 275:13677-13682.
16. Rommel, C., S. C. Bodine, B. A. Clarke, R. Rossman, L. Nunez, T. N. Stitt, G. D. Yancopoulos, and D. J. Glass. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/ Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3:1009-1013.
17. Spurlock, D. M., T. G. McDaneld, and L. M. McIntyre. 2006. Changes in skeletal muscle gene expression following clenbuterol administration. BMC Genomics 7:320.
18. Sumitani, S., K. Goya, J. R. Testa, H. Kouhara, and S. Kasayama. 2002. Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gène transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology 143:820-828.
19. Wilcox, A., K. D. Katsanakis, F. Bheda, and T. S. Pillay. 2004. ASB6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex. J. Biol. Chem. 279:38881-38888.
20. Xu, Q., and Z. Wu. 2000. The insulin-like growth factor-phosphati- dylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J. Biol. Chem. 275:36750-36757.
21. Yang, W., Y. Chen, Y. Zhang, X. Wang, N. Yang, and D. Zhu. 2006. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. Cancer Res. 66:1320-1326.